Put Options

9 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$324.3 - $354.67 $648,600 - $709,340
2,000 Added 25.32%
9,900 $3.37 Million
Q1 2024

May 13, 2024

BUY
$293.94 - $358.71 $2.32 Million - $2.83 Million
7,900 New
7,900 $2.83 Million
Q1 2023

May 12, 2023

BUY
$246.13 - $285.47 $6.65 Million - $7.71 Million
27,000 New
27,000 $7.71 Million
Q1 2022

May 16, 2022

SELL
$245.33 - $277.77 $2.7 Million - $3.06 Million
-11,000 Reduced 55.0%
9,000 $2.41 Million
Q2 2021

Aug 13, 2021

BUY
$242.95 - $267.0 $4.52 Million - $4.97 Million
18,600 Added 1328.57%
20,000 $5.2 Million
Q2 2018

Aug 14, 2018

SELL
$155.17 - $179.78 $93,101 - $107,868
-600 Reduced 30.0%
1,400 $236,000
Q3 2017

Nov 14, 2017

SELL
$138.36 - $147.87 $152,196 - $162,657
-1,100 Reduced 35.48%
2,000 $284,000
Q2 2017

Aug 14, 2017

BUY
N/A
2,800 Added 933.33%
3,100 $430,000
Q1 2017

Nov 14, 2017

BUY
N/A
300
300 $40,000

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $136B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.